Navigation Links
C-Reactive Protein, High Sensitivity

ProductsC-Reactive Protein, High Sensitivity
Company ARUP Laboratories
Item C-Reactive Protein, High Sensitivity
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. RCRP high sensitivity C-Reactive Protein (hsCRP)
2. C-Reactive Protein (CRP) Assay
3. C-Reactive Protein Assay
4. C-Reactive Protein - Rapid Test
5. Immunex CRP® C-Reactive Protein
6. C-Reactive Protein
7. C-Reactive Protein, Neonatal
8. Array® 360 Protein, Serology and Drug System
9. Array® 360 CEAL Protein, Serology and Drug System
10. Bence Jones Protein, Qualitative Free Kappa & Lambda Light Chains, Urine
11. Bence Jones Protein, Quantitative Free Kappa Light Chains, Urine
MIS Distal Femoral Alignment/Saw Guide and Intramedullary Rod
Ascent Anterior Referencing Femoral Instrument Case
Ascent Knee System Case # 2
Lineage Acetabular Cup System (Ceramic)
Medicine Products:
(Date:11/27/2009)...Mass., Nov. 27 GSI Group...ier of precision technology products and semicondu...ng of the Company,s shareholders has been schedule...on of the meeting will be announced in due course....requisition notice from Stephen Bershad, a holder ...
(Date:11/27/2009)...CO, Nov. 27 The Gymboree... Lambert, CFO/COO, will present at the NASDAQ OMX ...ay Fair Hotel in London, England, on Wednesday, De... to a live broadcast of The Gymboree Corporation,s...www.gymboree.com, click on "Our Company" at the bo...
(Date:11/27/2009)... XenaCare Holdings has announced that it has be...n, one of the largest nonprofit organizations dedi...ation. , Delray Beach, FL...nc. (OTCBB: XCHO), a company specializing in the m...hcare products, has announced today that is has be...
(Date:11/27/2009)... Voyant Health™ announced today that Spec...its TraumaCad Enterprise orthopedic templating sol... , (PRWEB) November 27, 20...ectrum Health (Grand Rapids, Michigan) has license...olution and its TraumaCad Extend workflow solution...
(Date:11/26/2009)...Nov. 27 With cold and flu season u...od practices to control the spread of infections a...ot only to keep ourselves healthy, but to avoid tr...erty, RN, MS, CIC (certified in infection-control)...ational health at Hospital for Special Surgery (HS...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...riods of blocked blood flow may be better conditio...cording to new research from the University of Cin... UC surgeon-scientist Karyn Butler, MD, found that...yknown as JAK-STATthat protects the heart muscle. ...
...,CVD) today announced that it will present at the ...ary 7 at 7:30 pm ET. Investors may access a,live w...com . In order to register,and download any necess...ive drug development services companies,with reven...
...he gym , , SATURDAY, Jan. 5 (HealthDay New...esolution list, and you don,t even need a gym memb... the correct home equipment, being creative and bo... is to lose weight, but it should not necessarily ...
....,Calvin B. Johnson today invited all Pennsylvania... exhibit at the Farm Show for free health,screenin... information., "Our Body Shop is a fun place for ...n staying fit, preventing,injuries, and detecting ...
...ional group,purchasing organization for the health...o Nonin Medical, Inc. Each year, Amerinet recogniz...nd services to health care,providers across the na...g to millions of people worldwide., "The Niche Su...
...cientists say , , FRIDAY, Jan. 4 (HealthDa...arkinson,s disease may be triggered by a harmful m...w research reveals. , The modification in question...earchers say. , The change short-circuits a proces...
Other Medicine News:Health News:Mini 'stress tests' could help condition heart to survive major attack 2Health News:Fitness Begins at Home 2Health News:Nonin Medical is Honored With Niche Supplier Award from Amerinet 2Health News:Research Gets Closer to Origin of Parkinson's Disease 2Health News:Research Gets Closer to Origin of Parkinson's Disease 3
(Date:11/25/2009)...e/ -- Reportlinker.com announces that a new market..., Mammography Equipment - A Global Market Pers...330/Mammography-Equipment---A-Global-Market-Perspe...r in industrialized as well as developing nations ...mmography market. Globally, escalating awareness a...
(Date:11/25/2009)...Newswire/ -- Cempra Pharmaceuticals Inc. today ann...hief executive officer, will present at the Piper ... a.m. EST, December 1, 2009, at The New York Palac...ide an overview of the company,s two leading antib...resistant pathogens including MRSA. ,, About C...
(Date:11/25/2009)...ewswire/ -- ChemoCentryx, Inc., announced today ... PROTECT-1 (the Prospective Randomized Oral Therap...-EN(TM) (CCX282-B) in patients with moderate-to-se...y with a favorable safety and tolerability profile...icacy in the reduction of disease severity as defi...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 1FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 2FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 3FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 4FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 5FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 6FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 7FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 8PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 1PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 3Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 1Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 2Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 3